As the 340B rebate pilot approaches its January 2026 launch, one of the most debated questions is whether covered entities should be required to submit purchase data to claim 340B rebates. At first glance, the idea may sound like a safeguard against duplicate discounts. But in practice, tying rebate claims to purchase data risks undermining the very integrity the pilot is supposed to protect. Read More >
Virtue 340B provides independent 340B risk oversight for hospitals and health systems operating in an increasingly complex and scrutinized program environment. Rather than managing programs or selling technology, Virtue delivers objective, independent analysis that helps leadership understand where hidden exposure may exist, what that exposure could mean operationally or financially, and whether current oversight would stand up under external scrutiny. Our work translates complex 340B operational realities into clear, defensible insights that executives can act on with confidence.
Through independent audits, mock HRSA audit simulations, and continuous compliance monitoring, Virtue helps organizations detect operational drift early, strengthen oversight structures, and maintain durable, audit-ready programs. By focusing on prevention, visibility, and governance, not just technical compliance, Virtue 340B equips leadership teams with the clarity they need to protect their organizations and confidently defend how their 340B programs are being managed.
This post is related to:
